<DOC>
	<DOCNO>NCT02276755</DOCNO>
	<brief_summary>The goal clinical trial investigate preventive role vitamin D supplementation school age child high transmission set . The investigator hypothesis ( 1 ) vitamin D supplementation reduce rate acquisition LTBI , ( 2 ) vitamin D supplementation lead great reduction active TB incidence , ( 3 ) child low vitamin D status baseline gain intervention .</brief_summary>
	<brief_title>Vitamin D Suplementation TB Prevention</brief_title>
	<detailed_description />
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Latent Tuberculosis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>1 . Healthy child age 6 13 year , enrol participate school 2 . Not currently TB infect , test QFTG test . 3 . Pupil give write informed assent participation trial 4 . Pupil 's parent / guardian give write informed consent participation . 1 . Chronic medical condition 2 . Presence LTBI screening , evidence positive QFTG 3 . Clinical sign rickets , diagnosis condition require vitamin D supplementation 4 . Known primary hyperparathyroidism sarcoidosis 5 . Taking immunosuppressant cytotoxic therapy , vitamin D supplement &gt; 400IU / day 6 . Plans move away study area within 3 year enrolment .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>13 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>